{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T03:04:36Z","timestamp":1767236676749,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cca.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T02:27:35Z","timestamp":1552012055000},"page":"48-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Galactosylsphingosine does not interfere with the quantitation of plasma glucosylsphingosine levels in Gaucher patients"],"prefix":"10.1016","volume":"494","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0138-2640","authenticated-orcid":false,"given":"Wei-Lien","family":"Chuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dritan","family":"Hoxha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Sanderink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.03.009_bb0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cca.2019.03.009_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2019.03.009_bb0015","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2019.03.009_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cca.2013.01.017","article-title":"Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease","volume":"419","author":"Chuang","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.03.009_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2013.11.012","article-title":"Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients","volume":"111","author":"Chuang","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2019.03.009_bb0030","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.03.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients","volume":"8","author":"Rolfs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.03.009_bb0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13023-016-0413-3","article-title":"Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients","volume":"11","author":"Smid","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"year":"2011","series-title":"Simultaneous Quantitative Analysis of Glucosylceramide and Galactosylceramide Species by Supercritical Fluid Chromatography Tandem Mass Spectrometry","author":"Snider","key":"10.1016\/j.cca.2019.03.009_bb0045"},{"key":"10.1016\/j.cca.2019.03.009_bb0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/glycob\/cwp047","article-title":"Simultaneous quantification of glucosylceramide and galactosylceramide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with sphingolipid ceramide N-deacylase","volume":"19","author":"Zama","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.cca.2019.03.009_bb0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","article-title":"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype","volume":"76","author":"Orvisky","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2019.03.009_bb0060","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1194\/jlr.D300010-JLR200","article-title":"Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride","volume":"44","author":"Bodennec","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2019.03.009_bb0065","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2015.12.006","article-title":"Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders","volume":"117","author":"Ferraz","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2019.03.009_bb0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ymeth.2005.01.009","article-title":"Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry","volume":"36","author":"Merrill","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.cca.2019.03.009_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114669","article-title":"Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-pick disease type C in a retrospective study","volume":"9","author":"Welford","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.03.009_bb0080","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.analchem.5b04227","article-title":"Tandem mass spectrometry multiplex analysis of glucosylceramide and galactosylceramide isoforms in brain tissues at different stages of Parkinson disease","volume":"88","author":"Boutin","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2019.03.009_bb0085","series-title":"Poster presentation at the 2016 AAPS Annual Meeting and Exposition","article-title":"Stereoisomer separation of drugs and biomarkers using supercritical fluid chromatography to support PK and PD studies","author":"Li","year":"2016"},{"key":"10.1016\/j.cca.2019.03.009_bb0090","series-title":"Document number: RUO-MKT-02-1868-A","article-title":"Differential ion mobility separation of glycosylceramides (Cerebrosides)","author":"Sanders","year":"1999"},{"key":"10.1016\/j.cca.2019.03.009_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010183","article-title":"Lipid and glycolipid isomer analyses using ultra-high resolution ion mobility spectrometry separations","volume":"18","author":"Wojcik","year":"2017","journal-title":"Int. J. Mol. Sci."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119301147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119301147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:47:34Z","timestamp":1757861254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119301147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":19,"alternative-id":["S0009898119301147"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.03.009","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galactosylsphingosine does not interfere with the quantitation of plasma glucosylsphingosine levels in Gaucher patients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}